In trading on Wednesday, the ARK Genomic Revolution ETF is outperforming other ETFs, up about 1.7% on the day. Components of that ETF showing particular strength include shares of 908 Devices, up...
908 Devices Inc. (NASDAQ:MASS Get Free Report) was the target of a significant decrease in short interest in October. As of October 31st, there was short interest totalling 1,360,000 shares...
This indicator may be signaling that MASS's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today announced that it has expanded access to its leading trace...
This indicator may be signaling that MASS's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
908 Devices (NASDAQ:MASS Get Free Report) posted its earnings results on Tuesday. The company reported ($0.22) earnings per share for the quarter, topping the consensus estimate of ($0.30) by...
908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today reported financial results for the quarter ended September 30...
908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, and medical technology company Terumo Blood and Cell Technologies...
For the last three days, A.I.dvisor has detected that MASS's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...
For the last three days, A.I.dvisor has detected that MASS's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...